Status:

COMPLETED

The Visceral Adiposity Measurement and Observation Study

Lead Sponsor:

Theratechnologies

Collaborating Sponsors:

Dacima Consulting

Medpace, Inc.

Conditions:

HIV

HIV-Infections

Eligibility:

All Genders

18+ years

Brief Summary

The Visceral Adiposity Measurement and Observation Study

Detailed Description

Visceral adiposity (VA) is a form of ectopic fat deposition that correlates with cardiometabolic risk in both the general population and among people with human immunodeficiency virus (HIV) (PWH).1 Ex...

Eligibility Criteria

Inclusion

  • Adult, ≥18 years
  • HIV+, on continuous ART for ≥12 months
  • ≥3 years since initiation of ART
  • 20.0 ≤ BMI ≤ 40.0 kg/m2

Exclusion

  • Detectable HIV plasma viremia 12 months prior enrollment, defined by ≥1 measurement of HIV-1 ribonucleic acid (RNA) \> 1000/mL
  • Unable or unwilling to undergo any study procedures
  • Known hepatic cirrhosis
  • Active hepatitis C within past 12 months, defined by detectable hepatitis C RNA
  • Hepatitis B positive
  • Current pregnancy or breastfeeding
  • History of liver transplant
  • Self-reported weekly alcohol consumption meets National Institute on Alcohol Abuse and Alcoholism (NIAAA) criteria for problematic drinking (binge or chronic daily intake)
  • Any active malignancy, excluding non-melanoma skin cancer
  • Patient has been treated with tesamorelin or human growth hormone within the last 12 months
  • Patient has used insulin in the previous year
  • Patient has undergone bariatric surgery in the year prior to enrollment or is currently undergoing a weight loss program

Key Trial Info

Start Date :

April 18 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 30 2023

Estimated Enrollment :

196 Patients enrolled

Trial Details

Trial ID

NCT05383456

Start Date

April 18 2022

End Date

October 30 2023

Last Update

November 18 2023

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Ruane Clinical Research

Los Angeles, California, United States, 90036

2

AIDS Healthcare Foundation

Fort Lauderdale, Florida, United States, 33308

3

AIDS Healthcare Foundation

Miami Beach, Florida, United States, 33133

4

AIDS Healthcare Foundation

Miami Beach, Florida, United States, 33140